206 related articles for article (PubMed ID: 26572077)
1. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
3. Nestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer.
Shan YS; Chen YL; Lai MD; Hsu HP
Oncol Rep; 2015 Jan; 33(1):40-8. PubMed ID: 25371063
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
5. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
[TBL] [Abstract][Full Text] [Related]
6. Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia.
Chen MC; Chen YL; Wang TW; Hsu HP; Lai MD
Oncol Rep; 2016 Oct; 36(4):1997-2008. PubMed ID: 27510297
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.
Cannistra SA; Abu-Jawdeh G; Niloff J; Strobel T; Swanson L; Andersen J; Ottensmeier C
J Clin Oncol; 1995 Aug; 13(8):1912-21. PubMed ID: 7543560
[TBL] [Abstract][Full Text] [Related]
9. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
[TBL] [Abstract][Full Text] [Related]
10. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
11. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
13. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
Hsu HP; Shan YS; Lai MD; Lin PW
Cancer Biol Ther; 2010 Jul; 10(2):144-54. PubMed ID: 20495367
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA.
Zhu L; Kim K; Domenico DR; Appert HE; Howard JM
J Surg Oncol; 1996 Feb; 61(2):100-5. PubMed ID: 8606540
[TBL] [Abstract][Full Text] [Related]
16. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
18. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
